Cargando…
Regular Insulin Administered With the V-Go Disposable Insulin Delivery Device in a Clinical Diabetes Setting: A Retrospective Analysis of Efficacy and Cost
Autores principales: | Sutton, David, Higdon, Charissa, Carmon, Mark, Abbott, Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070587/ https://www.ncbi.nlm.nih.gov/pubmed/27766012 http://dx.doi.org/10.2337/cd16-0021 |
Ejemplares similares
-
Clinical Insights Into a New, Disposable Insulin Delivery Device
por: Knutsen, P. Gaye, et al.
Publicado: (2015) -
The Clinical and Economic Impact of the V-Go(®) Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High Risk
por: Lajara, Rosemarie, et al.
Publicado: (2016) -
Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis
por: Sutton, David, et al.
Publicado: (2018) -
Delayed Response to U-500 Regular Insulin
por: Davidson, Mayer B.
Publicado: (2018) -
Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes
por: Mora, Pablo F, et al.
Publicado: (2020)